Bassam Awwa, MD - Medicare Psychiatry in New London, CT

Bassam Awwa, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in New London, Connecticut. He graduated from medical school in 1977 and has 47 years of diverse experience with area of expertise as Psychiatry. He is a member of the group practice Connecticut Behavioral Health Assoc, P.c. and his current practice location is 41 Fair Harbour Pl, New London, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 437-6914.

Bassam Awwa is licensed to practice in Connecticut (license number 024399) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1881774354.

Contact Information

Bassam Awwa, MD
41 Fair Harbour Pl,
New London, CT 06320-4710
(860) 437-6914
(860) 437-6920



Physician's Profile

Full NameBassam Awwa
GenderMale
SpecialityPsychiatry
Experience47 Years
Location41 Fair Harbour Pl, New London, Connecticut
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Bassam Awwa graduated from medical school in 1977
  NPI Data:
  • NPI Number: 1881774354
  • Provider Enumeration Date: 10/17/2006
  • Last Update Date: 09/27/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 5193613198
  • Enrollment ID: I20091028000687

Medical Identifiers

Medical identifiers for Bassam Awwa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1881774354NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 24399 (Connecticut)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 024399 (Connecticut)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Connecticut Behavioral Health Assoc, P.c.438553237335

News Archive

Short-term exposure to air pollution increases risk of heart failure

Short-term exposure to most major air pollutants appears to increase the risk of being hospitalised for and dying from heart failure, according to a systematic review and meta-analysis of data from 12 countries published in The Lancet.

Companies with healthy workforces have competitive edge in stock market

A new study finds companies with healthy workforces appear to have a competitive edge in the stock market. The study compared the stock market performance of ten of the healthiest companies in South Africa to the market at large. Nine different investment scenarios were tested and, in all nine scenarios, the healthy companies outperformed the Johannesburg Stock Exchange All Share Index.

FDA grants fast track designation to Genervon Biopharmaceuticals for ALS drug GM604

In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS. FDA said it met the necessary criteria.

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Bassam Awwa allows following entities to bill medicare on his behalf.
Entity NameConnecticut Behavioral Health Assoc, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629158126
PECOS PAC ID: 4385532373
Enrollment ID: O20040310000567

News Archive

Short-term exposure to air pollution increases risk of heart failure

Short-term exposure to most major air pollutants appears to increase the risk of being hospitalised for and dying from heart failure, according to a systematic review and meta-analysis of data from 12 countries published in The Lancet.

Companies with healthy workforces have competitive edge in stock market

A new study finds companies with healthy workforces appear to have a competitive edge in the stock market. The study compared the stock market performance of ten of the healthiest companies in South Africa to the market at large. Nine different investment scenarios were tested and, in all nine scenarios, the healthy companies outperformed the Johannesburg Stock Exchange All Share Index.

FDA grants fast track designation to Genervon Biopharmaceuticals for ALS drug GM604

In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS. FDA said it met the necessary criteria.

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bassam Awwa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Bassam Awwa, MD
41 Fair Harbour Pl,
New London, CT 06320-4710

Ph: (860) 437-6914
Bassam Awwa, MD
41 Fair Harbour Pl,
New London, CT 06320-4710

Ph: (860) 437-6914

News Archive

Short-term exposure to air pollution increases risk of heart failure

Short-term exposure to most major air pollutants appears to increase the risk of being hospitalised for and dying from heart failure, according to a systematic review and meta-analysis of data from 12 countries published in The Lancet.

Companies with healthy workforces have competitive edge in stock market

A new study finds companies with healthy workforces appear to have a competitive edge in the stock market. The study compared the stock market performance of ten of the healthiest companies in South Africa to the market at large. Nine different investment scenarios were tested and, in all nine scenarios, the healthy companies outperformed the Johannesburg Stock Exchange All Share Index.

FDA grants fast track designation to Genervon Biopharmaceuticals for ALS drug GM604

In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS. FDA said it met the necessary criteria.

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.

Read more News

› Verified 9 days ago


Psychiatry & Neurology Doctors in New London, CT

Bilal Hameed, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 194 Howard St Ste 1, New London, CT 06320
Phone: 860-440-0640    Fax: 860-865-2397
Dr. Sherrie Sharp, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 255 Hempstead St, New London, CT 06320
Phone: 860-443-2896    
Dr. Henry F Crabbe, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 5 Shaws Cv Ste 207, New London, CT 06320
Phone: 860-444-8877    Fax: 860-444-9660
Dr. Louis Henry Reich, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 292 Montauk Avenue, New London, CT 06320
Phone: 860-443-1200    Fax: 860-442-4488
Dr. Stephen Glenn Vance, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 21 Montauk Ave, New London, CT 06320
Phone: 860-439-6400    Fax: 860-271-4797
Dr. Ammar S Traboulsi, MD
Psychiatry & Neurology
Medicare: May Accept Medicare Assignments
Practice Location: 41 Fair Harbour Pl, New London, CT 06320
Phone: 860-437-6914    
Amy Stevens, M.D.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 365 Montauk Ave, New London, CT 06320
Phone: 860-271-4655    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.